Brief: Cereno Scientific Secures SEK 100 Mln Through Loan Financing, Conversion To Advance HDAC Inhibitors
20/06/2025 07:57
June 20 (Reuters) - Cereno Scientific AB CRNOSb.ST: SECURES 100 MSEK THROUGH ADDITIONAL LOAN FINANCING AND CONVERSION TO ADVANCE HDAC INHIBITORS CS1 AND CS014 IN PHASE II Source text: ID:nWkr9xpYNt Further company coverage: [CRNOSb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Carries Out Directed Share Issue Of SEK 60 Mln
Brief: Cereno Scientific Strengthens Patent Protection For Cs1 In Canada
Sweden's Cereno Scientific Q1 net loss widens amid clinical development
Brief: Cereno Scientific Q1 Loss After Financial Items SEK 28.6 Mln
Brief: Cereno Enters Collaboration With PHA Europe & Global